CoChat

ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells

Open access
Zong, Yang, Xin, Li, Goldstein, Andrew S., Lawson, Devon A., Teitell, Michael A., Witte, Owen N. · 2009 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.

Abstract

Chromosomal rearrangements involving erythroblast transformation specific (ETS) family transcription factors were recently defined as the most common genetic alterations in human prostate cancer. Despite their prevalence, it is unclear what quantitative role they play in either initiation or progression of the disease. Using a lentiviral transduction and dissociated cell prostate regeneration approach, we find that acutely increased expression of ETS proteins in adult murine prostate epithelial cells is sufficient to induce the formation of epithelial hyperplasia and focal prostatic intraepithelial neoplasia (PIN) lesions, but not progression to carcinoma. However, combined expression of ERG with additional genetic alternations associated with human prostate cancer can lead to aggressive disease. Although ERG overexpression does not cooperate with loss of the tumor suppressor p53, it does collaborate with alterations in PI3K signaling, such as Pten knockdown or AKT up-regulation, to produce a well-differentiated adenocarcinoma. Most striking is our finding that overexpression of androgen receptor (AR) does not give rise to any hyperplastic lesions, but when combined with high levels of ERG, it promotes the development of a more poorly differentiated, invasive adenocarcinoma. These findings suggest that in human prostate cancer, the most potent function of ETS gene fusions may be to synergize with alternative genetic events and provide different pathways for carcinoma production and invasive behavior. Our results provide direct evidence for selective cooperating events in ERG-induced prostate tumorigenesis and offer a rational basis for combined therapeutic interventions against multiple oncogenic pathways in prostate cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1073/pnas.0905931106

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Cited by

See all 203

Metadata

Authors
Zong, Y., Xin, L., Goldstein, A. S., Lawson, D. A., Teitell, M. A., & Witte, O. N.
Affiliations
  • Howard Hughes Medical Institute (US)
  • Department of Microbiology, Immunology, and Molecular Genetics,
  • Molecular Biology Institute,
Venue
Proceedings of the National Academy of Sciences
Published
2009-07-28
Volume
106
Issue
30
Pages
12465-12470
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1963749564
Cited by
203
References
46
Citations by year
2026: 1 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 11 · 2018: 7 · 2017: 12 · 2016: 11 · 2015: 13 · 2014: 22 · 2013: 35 · 2012: 21
FWCI
19.09
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Howard Hughes Medical Institute
  • Prostate Cancer Foundation
  • Leukemia and Lymphoma Society
  • National Cancer Institute (R00CA125937)
  • National Institute of General Medical Sciences (GM-07185, T32GM007185)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
  • Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
Keywords
ETS transcription factors, ERG, prostate cancer, prostate tumorigenesis, prostatic intraepithelial neoplasia, epithelial hyperplasia, PI3K signaling, PTEN loss, Akt, androgen receptor, p53, tumor suppressor loss, adenocarcinoma differentiation, invasive carcinoma
MeSH terms
Transcriptional Regulator ERG, Red Fluorescent Protein, Animals, Cell Transformation, Neoplastic, Cells, Cultured, DNA-Binding Proteins, Epithelial Cells, Hyperplasia, Immunohistochemistry, Luminescent Proteins, Male, Mice, Inbred C57BL, Mutation, Prostate, Prostatic Neoplasms, Transcription Factors, Blotting, Western, Signal Transduction, Oncogene Proteins, Tumor Suppressor Protein p53, Proto-Oncogene Proteins c-myc, Proto-Oncogene Proteins c-jun, Prostatic Intraepithelial Neoplasia, Phosphatidylinositol 3-Kinases, Integrin alpha6, Proto-Oncogene Proteins c-ets, Mice, Keratin-5

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells. https://app.cochat.ai/papers/10.1073/pnas.0905931106
The paper
Zong, Y., Xin, L., Goldstein, A. S., Lawson, D. A., Teitell, M. A., & Witte, O. N. (2009). ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0905931106

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.